A detailed history of Two Sigma Investments, LP transactions in United Therapeutics Corp stock. As of the latest transaction made, Two Sigma Investments, LP holds 141,086 shares of UTHR stock, worth $44.9 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
141,086
Previous 89,579 57.5%
Holding current value
$44.9 Million
Previous $19.7 Million 64.54%
% of portfolio
0.08%
Previous 0.05%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $10.9 Million - $12.9 Million
51,507 Added 57.5%
141,086 $32.4 Million
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $5.49 Million - $6.57 Million
25,565 Added 39.94%
89,579 $19.7 Million
Q3 2023

Nov 14, 2023

BUY
$211.82 - $248.24 $3.77 Million - $4.41 Million
17,782 Added 38.46%
64,014 $14.5 Million
Q2 2023

Aug 14, 2023

SELL
$205.19 - $232.99 $16.5 Million - $18.7 Million
-80,199 Reduced 63.43%
46,232 $10.2 Million
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $16.8 Million - $21.8 Million
78,812 Added 165.51%
126,431 $28.3 Million
Q4 2022

Feb 14, 2023

BUY
$205.95 - $280.43 $9.54 Million - $13 Million
46,317 Added 3557.37%
47,619 $13.2 Million
Q3 2022

Nov 14, 2022

BUY
$203.3 - $244.17 $264,696 - $317,909
1,302 New
1,302 $273,000
Q3 2021

Nov 15, 2021

BUY
$179.86 - $214.88 $18.3 Million - $21.8 Million
101,615 Added 223.05%
147,173 $27.2 Million
Q1 2021

May 17, 2021

BUY
$153.94 - $174.85 $7.01 Million - $7.97 Million
45,558 New
45,558 $7.62 Million
Q4 2020

Feb 16, 2021

SELL
$101.87 - $151.79 $3.37 Million - $5.03 Million
-33,127 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$99.9 - $121.13 $17.9 Million - $21.7 Million
-178,740 Reduced 84.36%
33,127 $3.35 Million
Q2 2020

Aug 14, 2020

SELL
$92.74 - $125.82 $5.89 Million - $7.99 Million
-63,525 Reduced 23.07%
211,867 $25.6 Million
Q1 2020

May 15, 2020

BUY
$79.39 - $115.35 $679,419 - $987,165
8,558 Added 3.21%
275,392 $26.1 Million
Q4 2019

Feb 14, 2020

SELL
$78.31 - $95.34 $16.2 Million - $19.7 Million
-206,724 Reduced 43.65%
266,834 $23.5 Million
Q3 2019

Nov 14, 2019

SELL
$74.85 - $85.99 $14.8 Million - $17 Million
-198,037 Reduced 29.49%
473,558 $37.8 Million
Q2 2019

Aug 14, 2019

BUY
$76.06 - $120.81 $44.3 Million - $70.3 Million
582,102 Added 650.44%
671,595 $52.4 Million
Q1 2019

May 15, 2019

BUY
$107.15 - $126.84 $3.2 Million - $3.79 Million
29,903 Added 50.18%
89,493 $10.5 Million
Q4 2018

Feb 14, 2019

SELL
$101.4 - $128.73 $4.89 Million - $6.2 Million
-48,176 Reduced 44.7%
59,590 $6.49 Million
Q3 2018

Nov 14, 2018

BUY
$113.81 - $129.46 $12.3 Million - $14 Million
107,766 New
107,766 $13.8 Million
Q2 2018

Aug 14, 2018

SELL
$101.14 - $118.31 $861,611 - $1.01 Million
-8,519 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$107.21 - $151.94 $3.55 Million - $5.03 Million
-33,136 Reduced 79.55%
8,519 $957,000
Q4 2017

Feb 14, 2018

BUY
$118.58 - $151.28 $4.94 Million - $6.3 Million
41,655
41,655 $6.16 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.